Abstract-N,N-Diallyl derivatives of enkephalin analogues were chemically syn thesized, and their biological activities were estimated in in vitro isolated preparations. test compound I] at doses up to 10 eeM did not inhibit the electrically-evoked contractions of guinea-pig ileum, which had been suggested to contain opioid mu and kappa-receptors, but it significantly depressed the contractions of mouse vas deferens, which had been indicated to contain mu-, kappa and delta-receptors, suggesting that test compound I did not act on both mu and kappa-receptors, but acted on delta-receptors. Additionally, the Ke (equilibrium dissociation constant) values againsttest compound I of naloxone were approximately 30 nM and similar to those of Mr 2266, also indicating that test compound I acted as a delta agonist.
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Moreover, the Ke values of ICI 154129 against compound I were approximately 340 nM, strongly suggesting that test compound I acted as a delta agonist.
The in guinea-pig ileum were 44.9 nM and 5.00 or 11.3 /tM, respectively, showing that test compound II was a potent selective opioid delta antagonist.
In conclusion, among compounds syn thesized, two new opioid delta-receptor ligands, one being a highly selective agonist and the other being a potent selective antagonist in in vitro isolated preparations, were found in the present study. is a weak mixed agonist-antagonist in in vitro isolated prepa rations such as guinea-pig ileum and mouse vas deferens and is not a selective delta antagonist (1).
In contrast to N-monoallyl substitution, N,N-diallyl substitution of enkephalin ana logues has been reported to exhibit a selective antagonism at the delta-receptor (2).
However, the effectiveness of such delta antagonists as ICI 139462 and ICI 154129 to antagonize the agonist action of delta agonists like enkephalins was approximately ten times lower than that of naloxone (2). In the present investigation, therefore, N,N diallyl derivatives of potent delta agonists were chemically synthesized, and their bio logical activities were estimated in order to find a potent delta antagonist.
An unexpected compound, a highly selective delta agonist as well as an anti cipated compound, a potent delta antagonist, the effectiveness of which was approximately the same as that of naloxone, were found in the present study. 
Materials and Methods

Chemicals
by the dimethylphos phinothioic mixed anhydride method in solution (3). The final products were purified by preparative thin layer chromatography and by gel chromatography on Sephadex LH 20 in methanol. The purities of these products were established by elemental analysis and thin layer chromatography.
In vitro isolated preparations: Male ICR JCL mice weighing 30-40 g and male Hartley guinea-pigs weighing 300-500 g were used for this study. The myenteric plexus-longitudinal muscle strip of guinea-pig ileum and the mouse vas deferens were prepared, and the preparations were set up for electrical stimulation as described previously (4). The % inhibition of the stimulated muscle twitch produced by a drug was plotted against the log concentration of the drug to estimate the IC50 (concentration of the drug to produce 50% inhibition of the twitch). The Ke (equilibrium dissociation constant) values of opioid antagonists against opiold agonists were determined by the 'single' dose method of Kosterlitz Additionally, the antagonistic effectiveness of test compound I at doses more than 500 nM could not be estimated due to its agonist action on mouse vas deferens. (Table 4) . Additionally, higher doses of either ICI 154129 or test compound II were required to antagonize the inhibitory action of ethylketocyclazocine, a kappa agonist, than that of morphine. The fact that test compound I does not have an agonist activity in guinea-pig ileum, which has been indicated to contain both opioid mu and kappa-receptors (8) , but have a naloxone-reversible agonist activity in mouse vas deferens, which have been suggested to contain opioid mu-, kappa and delta-receptors (4, 7, 9), suggests that test compound I does not act on either mu or kappa-receptors as an agonist, but acts on delta-receptors as an agonist. Moreover, the fact that the agonist action of test compound I on mouse vas deferens is antagonized by either naloxone or Mr 2266 only at the relatively high Ke values (27-31 nM) also suggests that test compound I acts as a delta agonist on mouse vas deferens, since naloxone has been shown to have a high affinity to mu-receptors (Ke values ranging from 1 to 5 nM) and relatively low affinity to both kappa and delta-receptors (Ke values ranging from 10 to 50 nM) (7, 9) , while Mr 2266 has high affinity to both mu and kappa receptors (Ke values ranging from 1 to 5 nM) and relatively low affinity to delta-receptors (Ke values ranging from 10 to 50 nM) (7) . Finally, the observation that the agonist action of test compound I on mouse vas deferens is antagonized by ICI 154129, which is a weak but highly selective antagonist of delta-receptors (2), with an average Ke value of 336 nM, strongly indicates that test compound I acts as a delta agonist on mouse vas deferens, since the range of the Ke values of ICI 154129 against delta agonists has been reported to be from 250 to 900 nM (2). In contrast to two highly selective delta agonists, deltakephalin (10) and [D-Pen D2 Pen5] enkephalin (11) , the characteristic feature of test compound I is that it has no agonist action at all on guinea-pig ileum at doses up to 10 tiM, while the two already reported delta agonists have been shown to have agonist actions on guinea-pig ileum, IC50 values of deltakephalin and [D-Pence D PenS]-enkephalin being 0.46 and 6.9 /cM, respectively (10, 11) .
The fact that the Ke value of test compound II against [D-Ala2, D-Leu5]-enkephalin in mouse vas deferens is 44.9 nM shows that the effectiveness to antagonize the agonist action of the delta agonist of compound II is high enough and similar to that of naloxone.
Additionally, the fact that the Ke value of test compound II against either a mu or kappa agonist is more than 100 times higher than that against a delta agonist shows that the selectivity of test compound II is quite high, since the Ke value of naloxone against either a kappa or delta agonist is approximately 10 times higher than that against a mu agonist (7-9). While this manuscript was in prepa ration, it was reported that a new selective delta antagonist, ICI 174864, was equipotent with naloxone (12) . Thus, test compound II seems to be equipotent to ICI 174864 as a delta antagonist.
It is apparent that both selective agonists and antagonists are quite useful for studying 
